144 related articles for article (PubMed ID: 14675067)
1. Podocytes as a target for treatment with ACE inhibitors and/or angiotensin-receptor blockers.
Kriz W
Kidney Int; 2004 Jan; 65(1):333-4. PubMed ID: 14675067
[No Abstract] [Full Text] [Related]
2. Angiotensin converting enzyme inhibitors and progression of chronic renal failure.
Tolins JP; Raij L
Kidney Int Suppl; 1990 Nov; 30():S118-22. PubMed ID: 2259070
[TBL] [Abstract][Full Text] [Related]
3. [ACE inhibitors in kidney diseases--only another antihypertensive agent?].
Ritz E; Stein G
Med Klin (Munich); 1994 Sep; 89(9):473-5. PubMed ID: 7968882
[No Abstract] [Full Text] [Related]
4. [Renal effects of angiotensin-converting enzyme inhibitors and their therapeutic use in chronic terminal renal failure].
Ritz E; Mann JF; Rambausek M
Z Kardiol; 1988; 77 Suppl 3():57-60. PubMed ID: 2850688
[No Abstract] [Full Text] [Related]
5. Converting enzyme inhibitors and calcium antagonists in the long-term treatment of hypertension in chronic renal failure.
Lenz T; August P
Wien Klin Wochenschr; 1990 May; 102(11):315-9. PubMed ID: 2195780
[TBL] [Abstract][Full Text] [Related]
6. [Nephroprotection by inhibition of the renin-angiotensin system--wish or reality?].
Barnas U; Mayer G
Wien Klin Wochenschr; 1995; 107(1):10-4. PubMed ID: 7871784
[TBL] [Abstract][Full Text] [Related]
7. [Hypertension--special reference to kidney diseases].
Hayashi M
Nihon Jinzo Gakkai Shi; 2002; 44(5):432-8. PubMed ID: 12216475
[No Abstract] [Full Text] [Related]
8. Progressive renal insufficiency: the role of angiotensin converting enzyme inhibitors.
Savage S; Schrier RW
Adv Intern Med; 1992; 37():85-101. PubMed ID: 1558007
[TBL] [Abstract][Full Text] [Related]
9. Is it time for ACE inhibitors in chronic allograft nephropathy?
Lewis JB; Helderman JH
Am J Kidney Dis; 2000 Jan; 35(1):154-6. PubMed ID: 10620559
[No Abstract] [Full Text] [Related]
10. [ACE and AT1 inhibitors in used in the progression of chronic renal failure].
Switalski M
Pol Arch Med Wewn; 2002 Apr; 107(4):379-87. PubMed ID: 12189931
[No Abstract] [Full Text] [Related]
11. [ACE inhibitors and the kidney].
Hörl WH
Wien Med Wochenschr; 1996; 146(11):231-4; discussion 234-5. PubMed ID: 8928521
[TBL] [Abstract][Full Text] [Related]
12. ACE inhibition and renal protection.
Ritz E
Clin Physiol Biochem; 1992; 9(3):94-7. PubMed ID: 1302163
[TBL] [Abstract][Full Text] [Related]
13. Calcium channel blockers: effects on progressive renal disease.
Zucchelli P; Zuccalà A; Gaggi R
Am J Kidney Dis; 1991 May; 17(5 Suppl 1):94-7. PubMed ID: 2024684
[No Abstract] [Full Text] [Related]
14. Losartan in patients with renal insufficiency.
de Zeeuw D; Gansevoort RT; de Jong PE
Can J Cardiol; 1995 Aug; 11 Suppl F():41F-44F. PubMed ID: 7664217
[TBL] [Abstract][Full Text] [Related]
15. [Blood pressure goal and antihypertensive therapy in chronic kidney disease].
Rump LC
Dtsch Med Wochenschr; 2014 Nov; 139(48):2453-7. PubMed ID: 25409404
[No Abstract] [Full Text] [Related]
16. ACE inhibitors and survival of hemodialysis patients.
Efrati S; Zaidenstein R; Dishy V; Beberashvili I; Sharist M; Averbukh Z; Golik A; Weissgarten J
Am J Kidney Dis; 2002 Nov; 40(5):1023-9. PubMed ID: 12407648
[TBL] [Abstract][Full Text] [Related]
17. [Arterial hypertension and chronic kidney disease].
Mitchell A;
MMW Fortschr Med; 2013 Oct; 155(17):55-7. PubMed ID: 24340391
[No Abstract] [Full Text] [Related]
18. Effects of felodipine in patients with refractory hypertension and progressive renal disease.
Herlitz H; Nyberg G; Granérus G; Björck S; Aurell M
Scand J Urol Nephrol Suppl; 1988; 108():31-4. PubMed ID: 3163828
[No Abstract] [Full Text] [Related]
19. ACE inhibitors in renal disease.
Brunner HR
Kidney Int; 1992 Aug; 42(2):463-79. PubMed ID: 1405331
[No Abstract] [Full Text] [Related]
20. [Prevention of progression of kidney insufficiency].
Binswanger U
Schweiz Rundsch Med Prax; 1988 May; 77(19):511-3. PubMed ID: 3387739
[No Abstract] [Full Text] [Related]
[Next] [New Search]
